SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SPDR Gold Trust - SPDR Gold Shares

SPDR Gold Shares ETF

SPDR Gold Shares ETF ($GLD) is trending strongly as escalating geopolitical tensions, particularly surrounding U.S.-Europe tariff threats over Greenland, drive a significant risk-off sentiment across markets. The community is actively discussing gold's role as a premier safe haven, pushing prices to new highs amidst global instability and concerns over economic and financial system shifts.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is trending due to investor concerns surrounding its Q1 outlook and the strategic implications of its all-cash offer for Warner Bros. Discovery. Despite strong Q4 performance and subscriber growth, the community is actively discussing how projected heavier content spending and the pausing of share buybacks to fund the acquisition are pressuring margins and adding to debt load.

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

Apple is experiencing a significant downturn, with many in the community attributing the "brutal day" to broader geopolitical tensions and proposed tariffs. Traders are hotly debating whether the stock's historically oversold RSI levels present a "buy the dip" opportunity ahead of its upcoming earnings report or if further declines are imminent due to perceived stagnation in AI innovation.

Corvus Pharmaceuticals, Inc. engages in the development of immune modulator product candidates with the potential to treat solid cancers, T-cell lymphomas, autoimmune diseases, and infectious diseases. Its product pipeline includes B Cell Activator and Anti-CD73, Adenosine Production Inhibitor Anti-CD73, ITK Inhibitor, A2AR Inhibitor, Anti-CXCR2, and A2BR Inhibitor. The company was founded by Richard A. Miller, Peter A. Thompson, Joseph J. Buggy, and Erik Verner on January 27, 2014 and is headquartered in South San Francisco, CA.

Corvus Pharmaceuticals Inc

Corvus Pharmaceuticals is trending following positive Phase 1 clinical trial results for its atopic dermatitis drug, soquelitinib, which demonstrated strong efficacy and a favorable safety profile. This bullish catalyst is met with sharp community debate after the company announced a significant $150 million public offering, leading to discussions about the drug's long-term potential against immediate dilution concerns.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is currently trending due to significant insider buying, notably CEO Ryan Cohen's recent acquisition of 500,000 shares, which has energized the community. Investors are interpreting these buys as a strong bullish signal, intensifying speculation about a potential short squeeze and reinforcing long-term conviction amidst ongoing discussions of market dynamics.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

The Invesco QQQ Trust is trending amid heightened geopolitical concerns and tariff threats, sparking intense debate within the community regarding potential market weakness or an imminent "buy the dip" recovery. Many see the tech-heavy index facing a crucial test as underlying economic sentiment clashes with persistent dip-buying expectations.

United States Commodity Funds LLC - United States Oil Fund

United States Oil Fund

USO is trending as mounting geopolitical tensions, particularly surrounding assertive U.S. actions in Venezuela's oil sector and renewed threats against Iran, are fueling significant market conversation. Traders are actively debating whether potential supply disruptions and a growing "war premium" will overcome underlying oversupply concerns, positioning for heightened volatility in crude markets.

America's Oil Reserve for the Digital Age

U.S Oil

USOR CRYPTO is generating significant buzz due to its rapid price movement and a highly anticipated upcoming event, fueling widespread speculation about its potential for substantial gains. The community is actively discussing its sustained growth and increasing market capitalization, while also navigating concerns about its meme coin nature and verifying authentic purchasing methods amidst a flurry of activity.

United Airlines Holdings, Inc. is a holding company, which engages in the provision of transportation services. It operates through the following geographical segments: Domestic, Atlantic, Pacific, and Latin America. The company was founded on December 30, 1968 and is headquartered in Chicago, IL.

United Airlines Holdings Inc

United Airlines is trending strongly following a robust quarterly earnings report that exceeded profit expectations and offered an optimistic outlook for the current year. The community is actively discussing the airline's impressive growth in premium travel and loyalty programs, highlighting how its strategic focus is driving structural margin expansion and strengthening its market position against competitors.

The Kraft Heinz Co. engages in the manufacture and market of food and beverage products. It operates through the North America and International geographical segments. The company was founded on July 2, 2015, and is headquartered in Pittsburgh, PA.

Kraft Heinz Co

Kraft Heinz is actively discussed following a Morgan Stanley downgrade and concerns over perceived market manipulation, with many in the community viewing the suppressed price as a significant buying opportunity. Investors are highlighting its attractive dividend yield, the strategic company split planned for unlocking value, and new leadership as key factors for a potential turnaround. As a consumer staple, KHC is also drawing attention as a defensive play amidst broader market shifts.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

NRx Pharmaceuticals (NASDAQ:NRXP) Given "Buy" Rating at BTIG Research

BTIG Research reaffirmed a "buy" rating and set a $25.00 price target on shares of NRx Pharmaceuticals in a research note on Thursday...

<ul class="summary-bullets"><li>The move is a major step toward FDA approval of NRX-100, its investigational drug.</li><li>Currently, no FDA-approved medications exist specifically to treat suicidal thoughts, with electroshock therapy remaining the only sanctioned option.</li><li>Earlier, Osmind presented data from a 20,000-patient subset at the 2024 American Society of Clinical Psychopharmacology meeting.</li></ul>NRx Pharmaceuticals, Inc. (NRXP) on Wednesday announced that it has licensed Real World Evidence (RWE) from more than 70,000 U.S. patients who received either intravenous ketamine or nasal S-ketamine as part of their treatment.The move is a major step toward FDA approval of its investigational drug, NRX-100 (preservative-free ketamine), aimed at treating suicidal ideation in patients with depression and suicidal tendencies.&nbsp;<h2 class="st-heading-2">Collaboration With Osmind</h2>The RWE data comes from Osmind, a neuropsychiatry technology platform used across U.S. clinics, providing detailed, regulatory-grade patient records. This joint effort allows NRx to submit a comprehensive dataset to the FDA in support of Accelerated Approval for NRX-100 under its Fast Track Designation.&nbsp;The approach could mark a breakthrough, as currently no FDA-approved medications exist specifically to treat suicidal thoughts, with electroshock therapy remaining the only sanctioned option.Following the update,&nbsp;<a href="https://stocktwits.com/symbol/NRXP">NRx Pharmaceuticals' stock&nbsp;</a>traded over 21% higher in Wednesday’s premarket.&nbsp;On Stocktwits, retail sentiment around the stock jumped to ‘bullish’ territory from ‘bearish’ the previous day. Message volume shifted to ‘high’ from ‘normal’ levels in 24 hours.&nbsp;<h2 class="st-heading-2">Preliminary Findings And Expectations</h2>Earlier, Osmind presented data from a 20,000-patient subset at the 2024 American Society of Clinical Psychopharmacology meeting. Results suggested rapid improvement in depression and suicidal ideation with intravenous ketamine.&nbsp;NRx anticipates that analysis of the full 70,000-patient dataset will provide even stronger evidence to support the FDA submission.<blockquote>“An American commits suicide every 11 minutes and ketamine has become widely used off label as a drug that has been seen to reduce suicidal ideation in clinical trials.”-Jonathan Javitt, Chairman and CEO, NRx Pharmaceuticals</blockquote>NRXP stock has declined by over 58% in the last 12 months.&nbsp;Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/why-did-nrxp-stock-surge-pre-market-today/cmULXc2R4eL">Why Did NRXP Stock Surge 21% Pre-Market Today?</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, a hand holding a medical syringe seen displayed in front of the NRx Pharmaceuticals logo.

Why Did NRXP Stock Surge 21% Pre-Market Today?

The company is using a large US real-world evidence dataset to support its accelerated FDA approval for its ketamine-based drug.

Equity

The company is using a large US real-world evidence dataset to support its accelerated FDA approval for its ketamine-based drug.


D. Boral Capital Reaffirms "Buy" Rating for NRx Pharmaceuticals (NASDAQ:NRXP)

D. Boral Capital restated a "buy" rating and issued a $34.00 target price on shares of NRx Pharmaceuticals in a research report on Monday...

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Receives Consensus Recommendation of "Moderate Buy" from Analysts

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP - Get Free Report) has earned a consensus recommendation of "Moderate Buy" from the six research firms that are covering the firm, MarketBeat Ratings reports...

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Short Interest Up 38.2% in December

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP - Get Free Report) saw a large growth in short interest in the month of December. As of December 15th, there was short interest totaling 1,744,957 shares, a...

NRx Pharmaceuticals (NASDAQ:NRXP) Given Buy Rating at HC Wainwright

HC Wainwright reiterated a "buy" rating and set a $40.00 target price on shares of NRx Pharmaceuticals in a research note on Tuesday...

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Receives Average Rating of "Moderate Buy" from Analysts

Shares of NRx Pharmaceuticals, Inc. (NASDAQ:NRXP - Get Free Report) have received an average recommendation of "Moderate Buy" from the six brokerages that are presently covering the firm, Marketbeat...

BTIG Research Reiterates Buy Rating for NRx Pharmaceuticals (NASDAQ:NRXP)

BTIG Research reaffirmed a "buy" rating and set a $25.00 price objective on shares of NRx Pharmaceuticals in a research report on Wednesday...

What is HC Wainwright's Forecast for NRXP FY2025 Earnings?

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP - Free Report) - Equities researchers at HC Wainwright cut their FY2025 earnings per share estimates for shares of NRx Pharmaceuticals in a report issued on...

NRx Pharmaceuticals (NASDAQ:NRXP) Upgraded at Wall Street Zen

Wall Street Zen raised NRx Pharmaceuticals from a "sell" rating to a "hold" rating in a research note on Sunday...

NRX Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in developing novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company was founded by Jonathan C. Javitt on September 18, 2017 and is headquartered in Wilmington, DE.

NRX Pharmaceuticals Inc

Up 10% or more

0% to up 9%

Down 1% to 9%

Down 10% or more

The S&P 500 enters 2026 after a strong run. What kind of return do you expect this year?

How will the S&amp;P 500 perform in 2026?

NRXP
NRX Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest NRXP News

NRXPNRX Pharmaceuticals Inc